The level of knowledge about the consequences of oropharyngeal cancer treatment on sleep
quality remains poor. Because of a high level of risk of developing an Obstructive Sleep
Apnea Syndrome (OSAS), an accurate evaluation of the prevalence, of the risk factors and of
the impact on quality of life is important in order to propose preventive and therapeutic
solutions to these patients.